Archana Shubhakar
YOU?
Author Swipe
View article: Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease
Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease Open
A blood-based prognostic biomarker to guide clinical decision-making at diagnosis of inflammatory bowel disease (IBD) would be immensely helpful. We investigated a composite serum N-glycomic biomarker to predict future disease course in 24…
View article: DOP10 Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease
DOP10 Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease Open
Biomarkers to predict treatment response would be highly beneficial in the clinical management of inflammatory bowel disease (IBD). To that end we have investigated the validity of a composite N-glycomic biomarker from 10 µl of serum taken…
View article: High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes
High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes Open
N-Glycosylation is a fundamentally important protein modification with a major impact on glycoprotein characteristics such as serum half-life and receptor interaction. More than half of the proteins in human serum are glycosylated, and the…